Association between clinical outcomes and metformin use in adults with sickle cell disease and diabetes mellitus-Reference-Cited by-同舟云学术

Association between clinical outcomes and metformin use in adults with sickle cell disease and diabetes mellitus

Published:2019-11-01 Issue:21 Volume:3 Page:3297-3306
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Badawy Sherif M.¹²^ORCID,Payne Amanda B.³^ORCID

Affiliation:

1. Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL;

2. Division of Hematology, Oncology, and Stem Cell Transplant, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL; and

3. Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA

Abstract

Key Points Metformin use was associated with significantly fewer SCD-related health care utilization encounters and clinical events. Our findings provide the first evidence to suggest potential clinical benefits associated with metformin use in patients with SCD.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/3/21/3297/1504670/advancesadv2019000838.pdf

Reference81 articles.

1. Population estimates of sickle cell disease in the U.S;Hassell;Am J Prev Med,2010

2. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates;Piel;Lancet,2013

3. Sickle cell disease;Piel;N Engl J Med,2017

4. Sickle-cell disease;Rees;Lancet,2010

5. Centers for Disease Control and Prevention (CDC) . Data & statistics on sickle cell disease. Available at: www.cdc.gov/ncbddd/sicklecell/data.html. Accessed 10 March 2019.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Standardization of coding definitions for sickle cell disease complications: A systematic literature review;Pharmacoepidemiology and Drug Safety;2024-08-28

2. Management of diabetes mellitus patients with sickle cell anemia: Challenges and therapeutic approaches;Medicine;2024-04-26

3. Endocrinopathies in Hemoglobinopathies: What Is the Role of Iron?;International Journal of Molecular Sciences;2023-11-13

4. Barriers to medication adherence in sickle cell disease: A comprehensive theory‐based evaluation using the COM‐B model;Pediatric Blood & Cancer;2023-05-27

5. SGK1 inhibition induces fetal hemoglobin expression and delays polymerization in sickle erythroid cells;Blood Advances;2023-05-24